APA (7th ed.) Citation

Hansrivijit, P., Ortega-Montiel, J., Wexler, D. J., Patorno, E., & Paik, J. M. Utilization Trends of Dual GIP/GLP-1 Receptor Agonist, Newer Glucose-Lowering Medications, and Anti-Obesity Medications Among Patients With Chronic Kidney Disease With and Without Type 2 Diabetes. Elsevier.

Chicago Style (17th ed.) Citation

Hansrivijit, Panupong, Janinne Ortega-Montiel, Deborah J. Wexler, Elisabetta Patorno, and Julie M. Paik. Utilization Trends of Dual GIP/GLP-1 Receptor Agonist, Newer Glucose-Lowering Medications, and Anti-Obesity Medications Among Patients With Chronic Kidney Disease With and Without Type 2 Diabetes. Elsevier.

MLA (9th ed.) Citation

Hansrivijit, Panupong, et al. Utilization Trends of Dual GIP/GLP-1 Receptor Agonist, Newer Glucose-Lowering Medications, and Anti-Obesity Medications Among Patients With Chronic Kidney Disease With and Without Type 2 Diabetes. Elsevier.